[{"Assets_0_Q2_USD":302085000.0,"CommonStockSharesOutstanding_0_Q2_shares":36638000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":6810000.0,"NetIncomeLoss_1_Q2_USD":-6309000.0,"NetIncomeLoss_2_Q2_USD":-7651000.0,"StockholdersEquity_0_Q2_USD":187805000.0,"EarningsPerShareBasic_1_Q2_USD":-0.17,"EarningsPerShareBasic_2_Q2_USD":-0.21,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":36470000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":36338000.0,"Ticker":"GKOS","CIK":"1192448","name":"GLAUKOS CORP","OfficialName":"Glaukos Corporation Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2869781865.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20190808"}]